
A SPAC, Spinoff, And Short Squeeze Walk Into A Bar (NASDAQ:SCLX)
DNY59 Part 1 – The SPAC The story begins with Sorrento Therapeutics (NASDAQ:SRNE). The company is generally considered a battleground stock with multiple short-seller reports against the company and a moderately fervent retail base of […]